CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2018 Financial Results

Go back to CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2018 Financial Results
(NASDAQ: CRSP) Delayed: 59.37 -2.52 (4.07%)
Previous Close $61.89    52 Week High $18.88 
Open $62.44    52 Week Low $13.75 
Day High $62.80    P/E N/A 
Day Low $59.17    EPS $0.00 
Volume 214,859